Get the latest Atara Biotherapeutics, Inc. (ATRA) stock news and headlines to help you in your trading and investing decisions.

Review the current Atara Biotherapeutics Inc (ATRA:XNAS) dividend yield and history to decide if ATRA is the best investment for you.

At the halfway mark last year, 97 layoff rounds were reported, marking a 32% year-over-year increase for the first half of ...

Atara Biotherapeutics' cell therapy Ebvallo should be approved to treat Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD), according to the EMA's human medicines ...

Atara Biotherapeutics: Q1 Earnings Snapshot THOUSAND OAKS, Calif. AP) — Atara Biotherapeutics Inc. ATRA) on Thursday reported first-quarter net income of $38 million, after reporting a loss in the ...

Get the annual and quarterly balance sheet of Atara Biotherapeutics, Inc. (ATRA) including details of assets, liabilities and shareholders' equity.

Review the current Atara Biotherapeutics Inc (ATRA:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if ATRA is the best investment for you.

Zura Bio (ZURA) has announced the appointment of Eric Hyllengren as CFO, effective July 7, 2025. He will succeed Verender Badial, who will step down from the role and remain with the company as a ...

Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical-stage, multi-asset immunology company developing novel dual-pathway ...

Find the latest Atara Biotherapeutics, Inc. (ATRA) stock quote, history, news and other vital information to help you with your stock trading and investing.